SCV |
single chain of variable fragment |
LDC |
lymphodepletion chemotherapy |
CRS |
cytokine release syndrome |
ICANS |
immune-effector-cell-associated neurotoxicity syndrome |
IFN-γ |
interferon-gamma |
IL-6 |
interleukin-6 |
TNF-α |
tumor necrosis factor-alpha |
GM-CSF |
granulocyte–macrophage colony-stimulating factor |
APCs |
antigen-presenting cells |
DCs |
dendritic cells |
CD40L |
ligand for CD40 |
DAMPs |
danger-associated molecular patterns |
PT |
prothrombin time |
PPT |
partial thromboplastin time |
HLH |
hemophagocytic lymph histiocytosis |
ASTCT |
American Society for Transplantation and Cellular Therapy |
BBB |
blood–brain barrier |
CNS |
central nervous system |
TLS |
tumor lysis syndrome |
BCMA |
B cell maturation antigen |
CLS |
capillary leak syndrome |
OTOT |
on-target, off-tumor toxicity |
TAAs |
tumor-associated antigens |
TSAs |
tumor-specific antigens |
CBC |
complete blood count |
CRP |
C-reactive protein |
LDH |
lactate dehydrogenase |
ECG |
electrocardiogram |
sICAM |
soluble intercellular adhesion molecule |
sVCAM |
soluble vascular cell adhesion molecule |
FOLR1 |
folate receptor 1 |
TAG72 |
tumor-associated glycoprotein 72 |
IL-6R |
interleukin-6 receptor |
i.v. |
intravenous injection |
ICP |
intracranial pressure |